Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
EP Vantage - Brexit: Laying Out a Path for UK Healthcare
This report contains a series of articles published by EP Vantage looking at the implications of Brexit for the life science industries.
They highlight the most important issues for the sector, which include the future of drug and medical device regulation outside of European frameworks and implications for intellectual property.
- What Brexit means for life science funding and strategy
- The UK by numbers
- What Brexit means for drug regulation
- What Brexit means for medtech regulation
- What Brexit means for medtech patents
EP Vantage is an independent editorial team providing daily commentary and analysis that allows our readers to quickly understand what is important and why. Our high quality, data-driven analysis is trusted, insightful and thought provoking, enabling our readers to make informed decisions.
Confirm your details on form below to download this report